Inhibition of aromatic L-amino acid decarboxylase activity by human autoantibodies

Clin Exp Immunol. 2000 Jun;120(3):420-3. doi: 10.1046/j.1365-2249.2000.01250.x.

Abstract

A full-length rat cDNA clone encoding aromatic L-amino acid decarboxylase (AADC) (E.C. 4.1.1.28) was used for in vitro transcription and translation. The enzyme had catalytic activity (0. 2 pmol serotonin/microl lysate per min), and was stimulated 2.5-fold by the addition of excess pyridoxal phosphate. On size exclusion chromatography, AADC eluted as a single activity peak with an apparent mol. wt of 93 kD. This activity peak was immunoprecipitated by sera from patients with autoimmune polyendocrine syndrome type I (APS I) containing autoantibodies against AADC. Serum and purified IgG from these patients inhibited the enzyme activity (non-competitively) by 10-80%, while sera from APS I patients without autoantibodies and controls did not. This finding confirms and extends previous observations that APS I patients have inhibitory antibodies against key enzymes involved in neurotransmitter biosynthesis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Aromatic Amino Acid Decarboxylase Inhibitors*
  • Aromatic-L-Amino-Acid Decarboxylases / genetics
  • Autoantibodies / metabolism*
  • Catalysis
  • Chromatography, Gel
  • Female
  • Humans
  • Immune Sera
  • In Vitro Techniques
  • Male
  • Middle Aged
  • Polyendocrinopathies, Autoimmune / enzymology*
  • Polyendocrinopathies, Autoimmune / immunology*
  • Protein Biosynthesis
  • Pyridoxal Phosphate / pharmacology
  • Rats
  • Transcription, Genetic

Substances

  • Aromatic Amino Acid Decarboxylase Inhibitors
  • Autoantibodies
  • Immune Sera
  • Pyridoxal Phosphate
  • Aromatic-L-Amino-Acid Decarboxylases